Yehuda Handelsman MD FACP, FNLA, FASPC, FAHA, MACE

Summary

• Dr. Yehuda Handelsman is the medical director and principal investigator of the Metabolic Institute of America, and an endocrinologist in solo private practice in Tarzana, California. He developed and successfully utilizes a comprehensive and unique, multiple-intervention approach to the cardiometabolic high risk patient, preventing and managing obesity, diabetes, and cardiovascular disease.
  
  He has published and researched extensively, and is a frequent lecturer on diabetes, focusing on comprehensive approaches to managing diabetes: controlling obesity, HTN, lipids, and the prevention of kidney disease and cardiovascular disease. Handelsman is a nationally- and internationally-recognized expert on Diabetes, Obesity, insulin resistance, metabolic syndromes, pre-diabetes, Lipids, DM medications to include SGLT2i, GLP1ra, Insulin, The Cardiorenal Syndrome, the gut-brain connection, and prevention of Heart Failure and Cardiovascular Disease. He has consulted and lectured on lipodystrophy, thyroid and osteoporosis. He published over 145 peer reviewed original articles. His Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity”, was published by: Professional Communications, Inc.